FDA said consumers shouldn't take the weight-loss pill Venom Hyperdrive 3.0
Venom Hyperdrive 3.0, marketed by California-based Applied Lifescience Research Industries Inc., contains sibutramine, a chemical that can put people at risk for addiction and can increase peoples blood pressure and heart rate, according to a press release issued Tuesday by the FDA. Consumers who have the product should stop taking it immediately and contact their doctor if they are experiencing any adverse health effects, the agency said. Applied Lifescience Research initiated a recall of the product in late December after the FDA said the dietary supplement contained sibutramine, according to the agency's press release.
The FDA's announcement comes about a month after the agency said more than 60 weight-loss products were tainted with powerful ingredients, including those used in antiseizure medications and some chemicals suspected to cause cancer.
Venom Hyperdrive 3.0 comes in red plastic bottles and can be found in retail stores in the U.S., as well as in Canada, Poland, Sweden, Hungary, South Africa, the Netherlands, Australia, France and the United Kingdom.
Applied Lifescience Research's Web site says only "trace" amounts of sibutramine can be found in the product, the FDA said, but the agency's analysis showed Venom Hyperdrive contains a significant amount.
"Nowhere do we state that Venom Hyperdrive contained trace amounts of subutramine," said Charles Weller, general counsel for Applied Lifescience Research. He added that the company's Web site only mentioned that trace amounts of sibutramine weren't harmful, not that trace amounts were in the product.
Mr. Weller said the company had begun replacing Venom Hyperdrive 3.0 about six months ago with a newer version. He said the company isn't certain how the sibutramine got into the original product, but said he believes it was contaminated by raw-material suppliers in China.
Source: The Wall Street Journal
0 comments:
Post a Comment